FTXH Among Health Care ETFs
End-of-day Nov 20, 2026 · 33 Health care ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.8% | −5.7% | −3.4% | −1.2% | +27.2% | +33.0% | +77.0% | +64.3% | +145.2% | +131.0% |
| Peer average | −1.3% | −6.4% | −4.5% | −5.9% | +13.4% | +17.5% | +58.2% | +19.5% | +146.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$82 of every $1,000 in FTXH is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly and Company | Healthcare | 8.23% | $822.65 | 64K | $87.1M |
| 2 | ABBVAbbVie | Healthcare | 7.79% | $778.76 | 291K | $82.4M |
| 3 | JNJJohnson & Johnson | Healthcare | 7.08% | $707.68 | 280K | $74.9M |
| 4 | PFEPfizer | Healthcare | 6.82% | $681.51 | 2.6M | $72.1M |
| 5 | MRKMerck | Healthcare | 6.33% | $633.02 | 505K | $67.0M |
| 6 | VTRSViatris | Healthcare | 4.24% | $424.02 | 2.3M | $44.9M |
| 7 | REGNRegeneron Pharmaceuticals | Healthcare | 4.07% | $406.87 | 47K | $43.1M |
| 8 | BIIBBiogen | Healthcare | 4.02% | $401.69 | 172K | $42.5M |
| 9 | GILDGilead Sciences | Healthcare | 4.01% | $400.73 | 255K | $42.4M |
| 10 | ZTSZoetis | Healthcare | 3.69% | $368.99 | 484K | $39.1M |
| 11 | AMGNAmgen | Healthcare | 3.59% | $359.48 | 87K | $38.1M |
| 12 | UTHRUnited Therapeutics | Healthcare | 3.42% | $342.44 | 65K | $36.3M |
| 13 | VRTXVertex Pharmaceuticals Incorporated | Healthcare | 3.37% | $336.71 | 68K | $35.6M |
| 14 | INCYIncyte | Healthcare | 3.27% | $327.44 | 299K | $34.7M |
| 15 | BMYBristol-Myers Squibb Company | Healthcare | 3.08% | $307.50 | 558K | $32.6M |
of the $108B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 8.23% |
| 2 | ABBV | AbbVie | 7.79% |
| 3 | JNJ | Johnson & Johnson | 7.08% |
| 4 | PFE | Pfizer | 6.82% |
| 5 | MRK | Merck & | 6.33% |
| 6 | VTRS | Viatris | 4.24% |
| 7 | REGN | Regeneron Pharmaceuticals | 4.07% |
| 8 | BIIB | Biogen | 4.02% |
| 9 | GILD | Gilead Sciences | 4.01% |
| 10 | ZTS | Zoetis | 3.69% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 24, 2026 | Sep 30, 2026 | $0.0113 |
| Jun 25, 2026 | Jun 30, 2026 | $0.0920 |
| Mar 26, 2026 | Mar 31, 2026 | $0.0573 |
| Dec 12, 2025 | Dec 31, 2025 | $0.13 |
| Sep 25, 2025 | Sep 30, 2025 | $0.15 |
| Jun 26, 2025 | Jun 30, 2025 | $0.0892 |
| Mar 27, 2025 | Mar 31, 2025 | $0.0992 |
| Dec 13, 2024 | Dec 31, 2024 | $0.13 |
| Sep 26, 2024 | Sep 30, 2024 | $0.12 |
| Jun 27, 2024 | Jun 28, 2024 | $0.13 |
| Mar 21, 2024 | Mar 28, 2024 | $0.0676 |
| Dec 22, 2023 | Dec 29, 2023 | $0.12 |